NCT03582553View on ClinicalTrials.gov

Safety and Pharmacokinetics of an Extract of Naringenin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
Safety IssuesPharmacokinetics
Interventions
DIETARY_SUPPLEMENT

Naringenin

An extract of Citrus Sinensis containing naringenin and its precursor naringin

OTHER

Placebo

Cellulose

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
collaborator

Louisiana Clinical and Translational Science Center

OTHER

lead

Pennington Biomedical Research Center

OTHER

NCT03582553 - Safety and Pharmacokinetics of an Extract of Naringenin | Biotech Hunter | Biotech Hunter